In a recent decision, the National Advertising Division took a stance against using lash inserts in mascara advertising making specific performance claims.

Jennifer McKenzie outlines a few key points from the guidelines published by the Federal, British Colombia and Alberta Privacy Commissioners.

The Competition Bureau has made it clear that an enforcement priority is the practice of "drip pricing"; that is the advertisement of a price that is unattainable...

On November 21, 2022, the Minister of Health tabled the 2021 Annual Report of the Patented Medicine Prices Review Board.

Health Canada released a revised Guidance Document: Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs on June 28, 2019

On March 19, 2019, Health Canada published a Notice, announcing the launch of its e-Learning tool: Understanding How Medical Devices are Regulated in Canada – Premarket Regulation.

On May 30, 2019, the PMPRB published the 2018 edition of the Meds Pipeline Monitor, a horizon scanning report which provides a snapshot of the new drug landscape

On November 21, 2019, the Patented Medicine Prices Review Board (PMPRB) released draft Guidelines operationalizing the recent amendments to the Patented Medicines Regulations for consultation

On February 19, 2019, the Patented Medicine Prices Review Board (PMPRB) announced the publication of the 2017 edition of Meds Entry Watch.

On July 2, 2019, the PMPRB Steering Committee on the Modernization of Price Review Process Guidelines released its final report summarizing

As previously reported, British Columbia, Alberta, and New Brunswick have all launched biosimilar initiatives which require that patients switch from certain reference biologics to biosimilars for certain indications.

On January 17, 2019, the Federal Court of Appeal heard the Attorney General of Canada's appeal from a judicial review that quashed a Board decision that it has jurisdiction ...

Innovative Medicines Canada (IMC) has announced changes to its Code of Ethical Practices for the first time since the last significant update in 2014.

As previously reported, the Federal Court of Appeal (FCA) allowed in part Apotex's appeal of a decision awarding Eli Lilly over $100 million for Apotex's infringement ...

On May 8, 2019, Justice Roy dismissed Servier's application for a prohibition order under the pre-amended Patented Medicines (Notice of Compliance) Regulations for Canadian Patent No

On July 10, 2019, the government of Canada published the final version of the new Patent Rules, which will come into force October 30, 2019.

Patented Medicine Prices Review Board releases August 2018 NEWSletter.

In its April 2019 NEWSletter, the Patented Medicine Prices Review Board (PMPRB) announced that the Steering Committee on Guidelines Modernization would hold its final meeting on May 13, 2019, to discuss both a draft report of its deliberations and the Working Group's final report

On September 24, 2020, the Supreme Court of Canada denied leave to Apotex (Docket No. 39172) with respect to a decision affirming the quantum of profits payable to the Plaintiffs...

The Canadian Agency for Drugs and Technologies in Health (CADTH) has released a report titled Utilization of Innovator Biologics and Biosimilars for Chronic Inflammatory Diseases in Canada:...